What Does TRACON Pharmaceuticals Do?

Total employees21
HeadquartersSan Diego
Founded2004

TRACON Pharmaceuticals, Inc. (NASDAQ: TCON) is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer. Their strategy involves leveraging a unique product development platform to efficiently advance their pipeline. Key drug candidates include Envafolimab (a PD-L1 single-domain antibody administered by subcutaneous injection), YH001 (a CTLA-4 antibody with enhanced ADCC and CDC activities), TRC102 (a small molecule inhibitor of DNA base excision repair), and TRC253 (a novel androgen receptor inhibitor). TRACON aims to develop these candidates for various cancer indications, often through collaborations and partnerships.

Where Is TRACON Pharmaceuticals's Headquarters?

TRACON Pharmaceuticals officeTRACON Pharmaceuticals officeTRACON Pharmaceuticals officeTRACON Pharmaceuticals office
*Images sourced via web search. Rights belong to original owners

HQ Function

The San Diego headquarters serves as the central hub for TRACON's operations, including executive management, clinical development oversight, research strategy, business development, finance, and administrative functions.

Notable Features:

Located in the University Towne Centre (UTC) area, known for its concentration of life science companies and proximity to research institutions like UC San Diego. The office is likely a modern, professional space designed to facilitate collaboration and innovation.

Work Culture:

As a clinical-stage biopharmaceutical company, the work culture is likely fast-paced, science-driven, and results-oriented, with a strong emphasis on teamwork, innovation in oncology, and achieving clinical milestones.

HQ Significance:

The headquarters' location in San Diego provides TRACON with access to a rich ecosystem of talent, research collaborators, and service providers crucial for a biopharmaceutical company's growth and drug development efforts.

Values Reflected in HQ: The choice of a professional office in a leading biotech hub reflects TRACON's commitment to cutting-edge science, operational efficiency, and attracting skilled professionals in the competitive pharmaceutical industry.

Location:

TRACON Pharmaceuticals's global presence is primarily characterized by its clinical trial operations and strategic partnerships. While headquartered in the U.S., the company conducts clinical trials for its oncology drug candidates in multiple countries across North America, Europe, and Asia-Pacific. This involves collaboration with international Contract Research Organizations (CROs), clinical investigators, and research institutions. Their out-licensing and co-development agreements, such as those for Envafolimab, also extend their product development reach into international markets, notably in Greater China.

Street Address:

4350 La Jolla Village Drive, Suite 800

City:

San Diego

State/Province:

CA

Country:

USA

Where Else Does TRACON Pharmaceuticals Operate Around the World?

No additional office locations available.

Buying Intent Signals for TRACON Pharmaceuticals

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Who's Leading TRACON Pharmaceuticals? Meet the Executive Team

As of April 2025, TRACON Pharmaceuticals' leadership includes:

Charles P. Theuer, M.D., Ph.D. - President and Chief Executive Officer, Director
Scott B. Brown, M.D. - Chief Medical Officer
Sean Smart - Vice President, Finance and Accounting, Principal Financial Officer and Principal Accounting Officer

Who's Investing in TRACON Pharmaceuticals?

TRACON Pharmaceuticals has been backed by several prominent investors over the years, including:

Ikarian Capital, LLC
Renaissance Technologies, LLC
The Vanguard Group, Inc.
Geode Capital Management, LLC
BlackRock Fund Advisors

What Leadership Changes Has TRACON Pharmaceuticals Seen Recently?

Hire0
Exits0

Based on publicly available information and recent company announcements, TRACON Pharmaceuticals has maintained stability within its core executive leadership team over the past 12 months, with no major C-suite hires or departures publicly highlighted. The key roles of CEO, CMO, and Principal Financial Officer appear consistently filled.

What Technology (Tech Stack) Is Used byTRACON Pharmaceuticals?

Discover the tools TRACON Pharmaceuticals uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

TRACON Pharmaceuticals Email Formats and Examples

TRACON Pharmaceuticals likely utilizes a common corporate email format. While not publicly confirmed, a typical structure for companies of this nature is [first_initial][last]@[companydomain].com.

[first_initial][last]@traconpharma.com

Format

ctheuer@traconpharma.com

Example

80%

Success rate

What's the Latest News About TRACON Pharmaceuticals?

GlobeNewswire • March 12, 2024

TRACON Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update

TRACON Pharmaceuticals announced its financial results for the fourth quarter and full year ended December 31, 2023. The company also provided updates on its clinical pipeline, including Envafolimab, and key corporate activities....more

GlobeNewswire • January 23, 2024

TRACON Pharmaceuticals Announces Pricing of $8.0 Million Underwritten Public Offering

TRACON Pharmaceuticals announced the pricing of an underwritten public offering of 22,857,143 shares of its common stock and accompanying warrants to purchase up to 22,857,143 shares of common stock. The gross proceeds are expected to be approximately $8.0 million, intended for working capital and general corporate purposes....more

GlobeNewswire • January 9, 2024

TRACON Pharmaceuticals Announces Envafolimab BLA Acceptance in China

TRACON Pharmaceuticals announced that the Biologics License Application (BLA) for envafolimab for adult patients with previously treated microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR) advanced solid tumors has been accepted by China's National Medical Products Administration (NMPA)....more

Highperformr's free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including TRACON Pharmaceuticals, are just a search away.